What an ID/DD Agency Should Expect from Its Long-Term Care Pharmacy
An ID/DD agency should expect its pharmacy partner to see the whole operation, not just the prescription. On-time MARs, accurate labels, a real person on the phone, billing that respects the daily rate, and a second set of eyes when something looks off. Partnership in this work is not a sales line. It is what protects the agency from audit exposure, what keeps nurses focused on residents, and what makes the difference between a quiet month and a crisis month.
Key Takeaways
- A real partner sees the medications, the nurses, the billing, and the audit cycle as one job.
- On-time MAR delivery on the first of the month is the operational baseline, not a value-add.
- A real person on the phone matters more than any portal feature when something is wrong.
- Billing accuracy at the line level is the agency's audit defense years later.
What does partnership actually mean in ID/DD pharmacy?
Real partnership means the pharmacy sees the whole picture the agency is responsible for, and acts like the picture matters. Partnership is a word that gets cheapened by overuse. In long-term care pharmacy serving the ID/DD community, it has a specific meaning. The pharmacy is plugged into the agency's clinical workflow, billing structure, and audit cycle. When the pharmacy treats those pieces as separate from the script, the agency feels it everywhere except where the script gets filled.
The agencies that have been burned describe the same pattern. Everything looked fine until it did not. The MARs were sometimes late. Billing questions got passed around. The audit letter arrived two years after a switch and nobody could explain the routing decisions on the original claims. The signs were there, just below the surface.
What does on time actually mean for a MAR?
On time means the first of the month, every month, in the nurse's hand. Not the second, not the third, not after a phone call. This is the operational floor, not the ceiling. A nurse should never start a new month without the MAR in hand. A med counselor should never have to call the pharmacy on day one to ask where the cycle is. If those calls are happening, the pharmacy is operating below the partnership baseline, even if everything else looks fine.
"We are looking out for you. When we spot something off, we say something. When a question comes in, a real person picks up the phone. When an agency needs a second set of eyes on something, we are those eyes.” - Angelo Angerame, CEO, Hudson Regional LTC Pharmacy
How does billing accuracy fit into partnership?
The pharmacy is making routing decisions every day that affect the agency's audit exposure six years from now. Most agencies do not fully see this until they are inside an audit. The pharmacy's billing decisions feed two downstream systems at the same time. The immediate Medicaid claim and the agency's Consolidated Fiscal Report. When the routing is wrong, the agency is exposed on the audit side under 18 NYCRR 504.3, and the cost never reaches the CFR that feeds future rates. A pharmacy that understands this is doing partnership-level work at the line level.
Five Questions to Ask Your Pharmacy Partner This Quarter
- Who is our named contact, and how fast do they respond? A name and a response window. Both should be specific.
- How are you classifying daily-rate items versus Medicaid items? A real answer cites the rule.
- When was the last time you flagged something wrong before we asked? Proactive catches are the proof of a real second set of eyes.
- What does our MAR delivery look like, on time, every month? Pull the last three cycles and check.
- If we got an OMIG audit letter tomorrow, what would you do? The answer should be calm and specific.
Frequently Asked Questions
How do I evaluate my current pharmacy partner?
Start with three things. MAR on-time delivery, who picks up the phone, and how billing routing decisions get made. If the answers are vague on any of the three, that is the signal.
Is switching pharmacies disruptive?
Done well, no. The transition includes prescription transfers, facility onboarding, and training on the web portal. Residents should not feel the change.
What is the biggest risk in staying with a pharmacy that is not a true partner?
Audit exposure. The pharmacy's billing routing decisions compound for six years under 18 NYCRR 504.3. The current month may look fine. The audit reach is much longer.
How do I know if a pharmacy understands the ID/DD community?
Ask about daily-rate billing, CFR cost capture, OPWDD-specific workflows, and MAR cycle timing. A pharmacy that lives in the space will answer fluently. One that does not will pivot to features.
Sources
- Hudson Regional LTC Pharmacy. CEO Letter and Switching Long-Term Care Pharmacies. April 2026.
- New York State Office of the Medicaid Inspector General. Audit Protocols FAQ. omig.ny.gov.
- 18 NYCRR § 504.3, Duties of the Provider.




